Geneva, May 18 -- International Clinical Trials Registry received information related to the study (ChiCTR2600124276) titled 'Study on Efficacy and Safety of Aparlimenol Toripalimab Combined with Fruquintinib and Trifluridine/Tipiracil in the Treatment of Advanced Colorectal Cancer with Failure of Second-line and Above Standard Therapy' on May 9.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Condition:
colorectal cancer
Recruitment Status: Recruiting
Phase: 4
Date of First Enrollment: 2026-05-11
Target Sample Size: Experimental Group:20;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?...